| Name | Title | Contact Details |
|---|
We offer a unique suite of solutions, with a unique perspective on clinical research development. We focus on bringing together best-in-class science, technology and service to drive superior clinical outcome results for our clients and for their patients. Increasing the Power of Clinical Research Data.
Pleasantview Industries Inc is a Santa Clarita, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Uniform Teeth is reinventing how orthodontic care is delivered to be better, faster, and more affordable. We`re patient focused, technology-enabled, and work with an incredible team of orthodontists to make sure each patient has an amazing experience.
OncoGenex is a biopharmaceutical company committed to the development and commercialization of new therapies that address treatment resistance in cancer patients. OncoGenex has a diverse oncology pipeline, with each product candidate having a distinct mechanism of action and representing a unique opportunity for cancer drug development. OncoGenex and Teva Pharmaceutical Industries Ltd. have entered a global collaboration and licensing agreement to develop and commercialize OncoGenex' lead drug candidate, custirsen. Custirsen is currently in Phase 3 clinical development as a treatment in men with metastatic castrate-resistant prostate cancer and in patients with advanced, unresectable non-small cell lung cancer. Apatorsen is in Phase 2 clinical development and OGX-225 is currently in pre-clinical development.
MedCAD is a Dallas, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.